| Age |
1.0105 |
0.000 |
1.0094 |
1.0115 |
| Sex |
| Male |
Reference |
| Female |
0.9311 |
0.000 |
0.9092 |
0.9535 |
| Race |
| White |
Reference |
| Black |
1.0681 |
0.001 |
1.0260 |
1.1118 |
| American Indian, Aleutian or Eskimo |
1.1644 |
0.135 |
0.9535 |
1.4221 |
| Asian |
1.1191 |
0.009 |
1.0284 |
1.2179 |
| Pacific Islander |
1.0792 |
0.306 |
0.9327 |
1.2486 |
| Other |
1.2171 |
0.005 |
1.0613 |
1.3957 |
| Unknown |
0.8870 |
0.017 |
0.8039 |
0.9786 |
| Facility Type |
| Community Cancer Program |
Reference |
| Comprehensive Community Cancer Program |
0.9622 |
0.172 |
0.9104 |
1.0169 |
| Academic/Research Program |
0.9982 |
0.948 |
0.9459 |
1.0534 |
| Integrated Network Cancer Program |
0.9692 |
0.385 |
0.9031 |
1.0401 |
| Unknown |
1.2379 |
0.000 |
1.1556 |
1.3262 |
| Histology |
| Sarcoma, NOS |
Reference |
| Ewing's sarcoma |
0.9604 |
0.553 |
0.8403 |
1.0976 |
| Epithelioid sarcoma |
1.0373 |
0.564 |
0.9159 |
1.1749 |
| High grade undifferentiate |
| pleomorphic sarcoma |
0.7603 |
0.000 |
0.7292 |
0.7927 |
| Fibrosarcoma |
0.9256 |
0.001 |
0.8833 |
0.9699 |
| Solitary fibrous tumor |
0.9190 |
0.249 |
0.7961 |
1.0609 |
| Dermatofibrosarcoma protuberans |
1.0397 |
0.496 |
0.9296 |
1.1629 |
| Liposarcoma, NOS |
0.8076 |
0.000 |
0.7570 |
0.8616 |
| Liposarcoma, well differentiated |
0.8506 |
0.000 |
0.8019 |
0.9023 |
| Myxoid liposarcoma |
0.8806 |
0.000 |
0.8304 |
0.9338 |
| Round cell liposarcoma |
0.7276 |
0.000 |
0.6232 |
0.8496 |
| Pleomorphic liposarcoma |
0.8395 |
0.000 |
0.7732 |
0.9114 |
| Dedifferentiated liposarcoma |
0.9385 |
0.086 |
0.8730 |
1.0091 |
| Leiomyosarcoma |
0.8876 |
0.000 |
0.8518 |
0.9248 |
| Vascular sarcoma |
1.2166 |
0.000 |
1.1305 |
1.3092 |
| Rhabdomyosarcoma |
0.9758 |
0.669 |
0.8720 |
1.0919 |
| Synovial sarcoma |
0.9581 |
0.219 |
0.8949 |
1.0257 |
| Clear cell sarcoma |
1.0107 |
0.928 |
0.8028 |
1.2723 |
| Chondrosarcoma |
0.8556 |
0.001 |
0.7798 |
0.9387 |
| Malignant giant cell tumor |
0.6312 |
0.008 |
0.4482 |
0.8891 |
| Malignant peripheral nerve sheath tumor |
1.0179 |
0.604 |
0.9519 |
1.0884 |
| Alveolar soft part sarcoma |
0.7108 |
0.083 |
0.4829 |
1.0462 |
| Grade |
| Grade 1 |
Reference |
| Grade 2 |
1.1095 |
0.000 |
1.0639 |
1.1570 |
| Grade 3 |
1.3232 |
0.000 |
1.2716 |
1.3769 |
| Grade 4 |
1.3475 |
0.000 |
1.2910 |
1.4064 |
| Tumor Size |
1.0003 |
0.000 |
1.0002 |
1.0004 |
| Charlson-Deyo Score |
| no comorbid conditions |
Reference |
| 1 comorbid condition |
1.1577 |
0.000 |
1.1190 |
1.1979 |
| >1 comorbid condition |
1.4249 |
0.000 |
1.3335 |
1.5226 |
| Radiation-Surgery Sequence |
| No radiation therapy |
Reference |
| Radiation therapy before surgery |
0.9444 |
0.005 |
0.9075 |
0.9828 |
| Radiation therapy after surgery |
0.8025 |
0.000 |
0.7814 |
0.8243 |
| Chemotherapy |
| No chemotherapy |
Reference |
| Received chemotherapy |
0.9798 |
0.271 |
0.9448 |
1.0161 |
| Unknown |
0.8271 |
0.000 |
0.7688 |
0.8897 |
| Margin Status |
| R0 |
Reference |
| R1 |
1.1438 |
0.000 |
1.1024 |
1.1869 |
| R2 |
1.2412 |
0.000 |
1.1889 |
1.2957 |
